Trends in the incidence and treatment of parathyroid cancer in the United States

Cancer

Volumn 109, Issue 9, 2007, Pages 1736-1741

  Lee, Peter K ^a   Jarosek, Stephanie L ^b   Virnig, Beth A ^b   Evasovich, Maria ^a   Tuttle, Todd M ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Hyperparathyroidism; Parathyroid cancer; Parathyroidectomy; Trends

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER THERAPY; FEMALE; GENDER; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; METASTASIS; PARATHYROID CARCINOMA; PARATHYROIDECTOMY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; TUMOR VOLUME; UNITED STATES;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PARATHYROID NEOPLASMS; PARATHYROIDECTOMY; SEER PROGRAM; SEX FACTORS; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 34247647377     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22599     Document Type: Article

References (14)

1. Fujimoto Y, Obara T, Ito Y, Kanazawa K, Aiyoshi Y, Nobori M. Surgical treatment of ten cases of parathyroid carcinoma: importance of an initial en bloc tumor resection. World J Surg. 1984;8:392-400.
2. Hakaim AG, Esselstyn CB Jr. Parathyroid carcinoma: 50-year experience at the Cleveland Clinic Foundation. Cleve Clin J Med. 1993;60:331-335.
3. Koea JB, Shaw JH. Parathyroid cancer: biology and management. Surg Oncol. 1999;8:155-165.
4. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: a National Cancer Data Base Report.The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1999;86:538-544.
5. Sandelin K, Auer G, Bondeson L, Grimelius L, Farnebo LO. Prognostic factors in parathyroid cancer: a review of 95 cases. World J Surg. 1992;16:724-731.
6. Wiseman SM, Rigual NR, Hicks WL Jr, et al. Parathyroid carcinoma: a multicenter review of clinicopathologic features and treatment outcomes. Ear Nose Throat J. 2004;83:491-494.
7. Munson ND, Foote RL, Northcutt RC, et al. Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer. 2003;98:2378-2384.
8. Busaidy NL, Jimenez C, Habra MA, et al. Parathyroid carcinoma: a 22-year experience. Head Neck. 2004;26:716-726.
9. Kleinpeter KP, Lovato JF, Clark PB, et al. Is parathyroid carcinoma indeed a lethal disease? Ann Surg Oncol. 2005;12:260-266.
10. Surveillance, Epidemiology, and End Results (SEER) Program About SEER. National Cancer Institute. Available at URL: http://www.seer.cancer.gov/about/
11. Bilezikian JP, Potts JT, Fuleihan Gel H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87:5353-5361.
12. Shorten CK, Andrus CH, Phillips CE Jr, Schwartz SI. Carcinoma of the parathyroid gland: a 30-year experience. Surgery. 1991;110:704-708.
13. Chow E, Tsang RW, Brierley JD, Filice S. Parathyroid carcinoma - the Princess Margaret Hospital experience. Int J Radiat Oncol Biol Phys. 1998;41:569-572.
14. Iacobone M, Lumachi F, Favia G. Up-to-date on parathyroid carcinoma: analysis of an experience of 19 cases J Surg Oncol. 2004;88:223-228.